Key result
SR 141716A pharmacology is reviewed in the context of the historical, socioreligious, and medicinal uses of Cannabis sativa.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May guide cannabinoid research directions; leaves open clinical translation of CB1 antagonists.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nakamura-Palacios et al. (1999) studied this question. SR 141716A pharmacology is reviewed in the context of the historical, socioreligious, and medicinal uses of Cannabis sativa.
Synapse has enriched 10 related papers. Consider them for comparative context: